ASCO Daily News: Genomic and Transcriptomic Profiling Finds Potential Predictors and Therapeutic Targets in Pancreatic Cancer

Dr. Mike Pishvaian discusses results from Perthera and PanCAN’s Know Your Tumor study, presented as Abstract 191 at ASCO GI 2019 in San Francisco, CA.

Perthera and the Pancreatic Cancer Action Network Publish Landmark Precision Medicine Study

Using real-world data from over 640 patients with pancreatic cancer, this landmark study demonstrated a 2.2 fold increase in progression-free survival for those being treated with a molecularly-matched therapy. Attached is a pdf of the press release.

Perthera to Host a Breakfast Symposium at the 2018 ASCO Annual Meeting

McLean, VA // Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be held in the Regency D ballroom of the Hyatt Regency McCormick Place, directly adjacent to the McCormick Place.

Perthera and Blue Faery Announce Their Partnership Against Liver Cancer

McLean, VA // Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual cancers.

Perthera and ZERO Announce the Decode Your Prostate Cancer Program

Washington, DC // ZERO is launching the Decode Your Prostate Cancer program in partnership with Perthera, the leading Therapeutics Intelligence Company™, to give men battling advanced prostate cancer the ability to create individualized treatment plans. Every patient’s prostate cancer is as unique as his genes. As we continue to fight this terrible disease, personalized medicine is more important than ever.

Perthera’s Subha Madhavan, Ph.D., to Speak at Prestigious Health 2.0 Conference

McLean, VA –(– Perthera Inc.’s, Subha Madhavan, PhD, Chief Bioinformatics Officer, will be speaking at the 11th Annual Fall Conference of Health 2.0 on Healthcare Innovations, Oct 1 – 4 in Santa Clara, CA, in the Personalized Health Track “Turning Data into Value.”


Contact Us